RO 438857

Drug Profile

RO 438857

Latest Information Update: 05 Feb 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Roche
  • Class Antiplatelets; Small molecules
  • Mechanism of Action Glucokinase stimulants; GPIIb-IIIa antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Thrombosis; Type 2 diabetes mellitus

Most Recent Events

  • 10 Jun 2008 Pharmacodynamics data from a clinical trial in patients with Type-2 diabetes mellitus presented at the 68th Annual Scientific Sessions of the American Diabetes Association (ADA-2008)
  • 15 Oct 1998 Discontinued - Preclinical trials for Thrombosis in Switzerland (PO)
  • 02 Feb 1996 An animal study has been added to the Thromboses pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top